Skip to content

Tempest Therapeutics, Inc.

TPST· NasdaqCore metricsCIK 1544227

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -3.62%
Market cap
$6.48M
16.89M shares
Filings
1,055
$55.00K
Q3 2018−54.8% FY17 yoy
-$3.63M
Q3 2026N/M FY25 yoy
-$2.82M
Q3 2026N/M FY25 yoy
-$10.38M
Q2 2026derivedN/M FY25 yoy
-$0.21
Q3 2026N/M FY25 yoy
$897.00K
Q3 2026−74.5% FY25 yoy
$6.48M
—
—
—
-414.07%
—

FY2025 figures · derived

Price

$0.383596.02%$9.2565past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$295.00KFY 2017
$653.00K0FY 2013FY 2014FY 2015FY 2016FY 2017
PeriodEndedValueKindSource trail
FY 20172017-12-31$295,000reported
FY 20162016-12-31$653,000reported
FY 20152015-12-31$277,000reported
FY 20142014-12-31$0reported
FY 20132013-12-31$0reported

Pharmaceutical preparations

Tempest Therapeutics, Inc. is the 442nd largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Tempest Therapeutics, Inc. · CIK 1544227 · Engraved from SEC EDGAR